|
MIDN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.553000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.331200E-01 |
| Normal-vs-Stage2 |
7.210000E-01 |
| Normal-vs-Stage3 |
5.887600E-01 |
| Normal-vs-Stage4 |
9.216400E-02 |
| Stage1-vs-Stage2 |
7.937000E-01 |
| Stage1-vs-Stage3 |
5.720300E-02 |
| Stage1-vs-Stage4 |
1.633660E-04 |
| Stage2-vs-Stage3 |
3.947600E-01 |
| Stage2-vs-Stage4 |
7.443800E-02 |
| Stage3-vs-Stage4 |
1.089810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.272200E-01 |
| Normal-vs-AfricanAmerican |
9.121700E-02 |
| Normal-vs-Asian |
6.489800E-01 |
| Caucasian-vs-AfricanAmerican |
2.997500E-02 |
| Caucasian-vs-Asian |
8.584000E-01 |
| AfricanAmerican-vs-Asian |
7.221700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.638200E-01 |
| Normal-vs-Female |
2.031400E-01 |
| Male-vs-Female |
2.140500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.577200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.628000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.977000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.738200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.633600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.821600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.083800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.922200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.926000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.946200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.339580E-01 |
| Normal-vs-Grade 2 |
3.426800E-01 |
| Normal-vs-Grade 3 |
4.323000E-01 |
| Normal-vs-Grade 4 |
2.105000E-01 |
| Grade 1-vs-Grade 2 |
1.965970E-01 |
| Grade 1-vs-Grade 3 |
8.733800E-02 |
| Grade 1-vs-Grade 4 |
6.255500E-02 |
| Grade 2-vs-Grade 3 |
1.136140E-02 |
| Grade 2-vs-Grade 4 |
9.299500E-03 |
| Grade 3-vs-Grade 4 |
4.409400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.844800E-01 |
| Normal-vs-ccB subtype |
8.350100E-02 |
| ccA subtype-vs-ccB subtype |
2.34219999999397E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.558200E-01 |
| Normal-vs-N1 |
3.219500E-03 |
| N0-vs-N1 |
4.958900E-04 |
|
|
